Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Emergent BioSolutions - Tough 2026 Outlook Warrant Rating Downgrade (NYSE:EBS)

Summary by Seeking Alpha
Emergent BioSolutions (EBS) downgraded to Hold as Narcan sales slip, competition rises and debt persists; review risks, cash flow signals and act now.

1 Articles

Seeking AlphaSeeking Alpha
Lean Right

Emergent BioSolutions - Tough 2026 Outlook Warrant Rating Downgrade (NYSE:EBS)

Emergent BioSolutions (EBS) downgraded to Hold as Narcan sales slip, competition rises and debt persists; review risks, cash flow signals and act now.

·Ra'anana, Israel
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Seeking Alpha broke the news in Ra'anana, Israel on Sunday, September 6, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Narcan icon

Narcan

Gaithersburg icon

Gaithersburg

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal